ISSN: 2228-5881 eISSN: 2251-7308

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics Indexing Info About APB & Contacts Indexing and Abstracting Articles In Press Archive

Journal Info:

Freq.: Quarterly

eISSN: 2251-7308
pISSN: 2228-5881

Permission: CC By

Platinum Open Access

(no submission or publication fees)

Abstracting and Indexing

PubMed Central, Pubmed,

Emerging Sources Citation Index

Scopus, Google Scholar,

EMBASE/Excerpta Medica

EBSCOhost; CAS: DOAJ

2024, Vol 14, No. 4

Advanced Pharmaceutical Bulletin (APB) is a peer-reviewed multidisciplinary open access journal, covering a wide range of various integrative fields with Pharmaceutical sciences.
APB is the official journal of Drug Applied Research Center and Faculty of Pharmacy, published by TUOMS PRESS, Tabriz University of Medical Sciences.

Publication Advantages in Advanced Pharmaceutical Bulletin are:

Free of charge publication for all types of articles
Fast and constructive peer review
Easy and quick online submission of manuscripts
Author friendly review
Rapid publication by means of running issue concept, which gives authors the benefit of 'No Waiting Time' for the officially accepted manuscripts
Free publication of color images
Worldwide visibility of papers (Open Access Journal)

Review Article

1. Effects of Mesenchymal Stem Cell Derivatives on Hematopoiesis and Hematopoietic Stem Cells

Sara Aqmasheh, karim Shamsasanjan*, Parvin Akbarzadehlaleh, Davod Pashoutan Sarvar, Hamzeh Timari

Adv Pharm Bull. 2017;7(2): 165-177. doi: 10.15171/apb.2017.021

PMCID: PMC5527230 PMID: 28761818 Scopus ID: 85021389670

Article

PDF

XML

Cited By:

Research Article

2. Restoration of miR-193a-5p and miR-146 a-5p Expression Induces G1 Arrest in Colorectal Cancer through Targeting of MDM2/p53

Saeed Noorolyai , Elham Baghbani , Leili Aghebati Maleki , Amir Baghbanzadeh Kojabad, Dariush Shanehbansdi, Vahid Khaze Shahgoli, Ahad Mokhtarzadeh , Behzad Baradaran*

Adv Pharm Bull. 2020;10(1): 130-134. doi: 10.15171/apb.2020.017

PMCID: PMC6983996 PMID: 32002372 Scopus ID: 85084315763

Article

PDF

Full Text

XML

Cited By:

Review Article

3. Roles of miRNAs in Colorectal Cancer: Therapeutic Implications and Clinical Opportunities

Amir Mehrgou , Shima Ebadollahi, Khaled Seidi, Mohammad Hosein Ayoubi-Joshaghani, Amirhossein Ahmadieh Yazdi, Peyman Zare, Mehdi Jaymand*, Rana Jahanban-Esfahlan*

Adv Pharm Bull. 2021;11(2): 233-247. doi: 10.34172/apb.2021.029

PMCID: PMC8046386 PMID: 33880345 Scopus ID: 85103156016

Article

PDF

Full Text

XML

Cited By:

Research Article

4. Protective Role of trans-Chalcone against the Progression from Simple Steatosis to Non-alcoholic Steatohepatitis: Regulation of miR-122, 21, 34a, and 451

Elham Karimi-Sales , Sajad Jeddi, Abbas Ebrahimi-Kalan, Mohammad Reza Alipour*

Adv Pharm Bull. 2022;12(1): 200-205. doi: 10.34172/apb.2022.022

PMCID: PMC9012929 PMID: 35517895 Scopus ID: 85127091326

Article

PDF

Full Text

XML

Cited By:

Research Article

5. microRNA‐193a‐5p Suppresses the Migratory Ability of Human KATO III Gastric Cancer Cells through Inhibition of Vimentin and MMP-9

Amir Baghbanzadeh , Elham Baghbani, Khalil Hajiasgharzadeh, Saeed Noorolyai, Vahid Khaze, Behzad Mansoori, Masoud Shirmohamadi, Behzad Baradaran* , Ahad Mokhtarzadeh*

Adv Pharm Bull. 2022;12(1): 169-175. doi: 10.34172/apb.2022.018

PMCID: PMC9012914 PMID: 35517889 Scopus ID: 85127121660

Article

PDF

Full Text

XML

Cited By:

Research Article

6. miR‐146a‐5p and miR-193a-5p Synergistically Inhibited the Proliferation of Human Colorectal Cancer Cells (HT-29 cell line) through ERK Signaling Pathway

Saeed Noorolyai , Elham Baghbani, Dariush Shanehbandi, Vahid Khaze Shahgoli, Amir Baghbanzadeh Kojabad, Behzad Mansoori, Khalil Hajiasgharzadeh, Ahad Mokhtarzadeh* , Behzad Baradaran*

Adv Pharm Bull. 2021;11(4): 755-764. doi: 10.34172/apb.2021.085

PMCID: PMC8642791 PMID: 34888223 Scopus ID: 85117194368

Article

PDF

Full Text

XML

Cited By:

Review Article

7. MicroRNAs and Periodontal Disease: Helpful Therapeutic Targets?

Abdolhakim Palideh , Mostafa Vaghari-Tabari, Ali Nosrati Andevari, Durdi Qujeq, Zatollah Asemi, Forough Alemi, Hemmatollah Rouhani Otaghsara, Sona Rafieyan* , Bahman Yousefi*

Adv Pharm Bull. 2023;13(3): 423-434. doi: 10.34172/apb.2023.048

PMCID: PMC10460817 PMID: 37646047

Article

PDF

Full Text

XML

Cited By:

Review Article

8. MicroRNAs as Targets for Cancer Diagnosis: Interests and Limitations

Behrouz Shademan , Vahidreza Karamad , Alireza Nourazarian, Sepideh Masjedi, Alireza Isazadeh, Fatma Sogutlu, Cigir Biray Avcı*

Adv Pharm Bull. 2023;13(3): 435-445. doi: 10.34172/apb.2023.047

PMCID: PMC10460809 PMID: 37646065

Article

PDF

Full Text

XML

Cited By:

Mini Review

9. The Role of Estrogen in Brain MicroRNAs Regulation

Peyvand Bahramiazar , Naseh Abdollahzade* , Bakhtyar Tartibian, Naser Ahmadiasl, Fakhreddin Yaghoob Nezhad*

Adv Pharm Bull. 2024;14(4): 819-835. doi: 10.34172/apb.39216

Article

PDF

XML

Cited By: